Matthew Peak
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
-
- Pharmaceutical studies and practices
Papers in
-
- Pharmaceutical studies and practices 24
-
- Metabolism, Diabetes, and Cancer 9
- Co-authors
- Loranne Agius (20 shared papers)M. Turner (20 shared papers)Anthony J Nunn (16 shared papers)Mohamed A. Alhnan (10 shared papers)Abdullah Isreb (8 shared papers)Molham Al‐Habori (4 shared papers)James L. Ford (7 shared papers)Munir Pirmohamed (10 shared papers)
- Journals
- PLoS ONE (9 papers)International Journal of Pharmaceutics (7 papers)Biochemical Journal (6 papers)BMJ Open (5 papers)Biochemical Society Transactions (5 papers)
- Partner nations
- United KingdomPolandBrazil
In The Last Decade
Matthew Peak
106 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 124
- Toxicology 121
- Pediatrics, Perinatology and Child Health 505
- Geriatrics and Gerontology 83
- Endocrinology, Diabetes and Metabolism 348
- Automotive Engineering 270
Countries citing papers authored by Matthew Peak
This map shows the geographic impact of Matthew Peak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Peak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Peak more than expected).
Fields of papers citing papers by Matthew Peak
This network shows the impact of papers produced by Matthew Peak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Peak. The network helps show where Matthew Peak may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Peak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 128 | |
| 2 | 1996 | 124 | |
| 3 | 1993 | 120 | |
| 4 | 2013 | 112 | |
| 5 | 2013 | 96 | |
| 6 | 2013 | 81 | |
| 7 | 2019 | 74 | |
| 8 | 1990 | 69 | |
| 9 | 2012 | 68 | |
| 10 | 2016 | 65 | |
| 11 | 1992 | 62 | |
| 12 | 2000 | 57 | |
| 13 | 2021 | 55 | |
| 14 | 2017 | 55 | |
| 15 | 1995 | 54 | |
| 16 | 1998 | 52 | |
| 17 | 1998 | 52 | |
| 18 | 2018 | 50 | |
| 19 | 2019 | 48 | |
| 20 | 2018 | 48 |
About Matthew Peak
Matthew Peak is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism and Biomedical Engineering, having authored 109 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (24 papers), Pancreatic function and diabetes (14 papers), Metabolism, Diabetes, and Cancer (9 papers), 3D Printing in Biomedical Research (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Diabetes Management and Research (6 papers), Additive Manufacturing and 3D Printing Technologies (6 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (5 papers). The work is most often cited by research in Toxicology (121 citations), Pediatrics, Perinatology and Child Health (505 citations), Geriatrics and Gerontology (83 citations), Endocrinology, Diabetes and Metabolism (348 citations) and Automotive Engineering (270 citations). Matthew Peak has collaborated with scholars based in United Kingdom, Poland and Brazil. Frequent co-authors include Loranne Agius, M. Turner, Anthony J Nunn, Mohamed A. Alhnan, Abdullah Isreb, Molham Al‐Habori, James L. Ford, Munir Pirmohamed, Utpal Shah and Roberta Richey. Their work appears in journals such as PLoS ONE, International Journal of Pharmaceutics, Biochemical Journal, BMJ Open and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.